NASDAQ
AREV Life Sciences Global Corp. (AREVF) has a free cash flow growth of 95.18% as of Friday, May 29, 2026. This represents a 167.81% increase compared to its 12-month average of -140.35%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.